000000827 001__ 827
000000827 005__ 20231128134410.0
000000827 0247_ $$2DOI$$a10.6083/M4RB72MN
000000827 037__ $$aETD
000000827 245__ $$aBCR-ABL mutations in chronic myeloid leukemia patients
000000827 269__ $$a2007
000000827 336__ $$aDissertation
000000827 502__ $$bPh.D.
000000827 540__ $$fCC BY
000000827 542__ $$fIn copyright - single owner
000000827 650__ $$aLeukemia$$021430
000000827 650__ $$aProtein-Tyrosine Kinases$$024762
000000827 650__ $$aAntineoplastic Agents$$014911
000000827 650__ $$aGenetics$$019472
000000827 650__ $$aDrug Therapy$$018086
000000827 6531_ $$atherapeutic use
000000827 6531_ $$abcr-abl positive
000000827 6531_ $$amyelogenous
000000827 6531_ $$achronic
000000827 6531_ $$aantagonists & inhibitors
000000827 691__ $$aSchool of Medicine$$041369
000000827 692__ $$aDepartment of Cell, Developmental and Cancer Biology$$041399
000000827 7001_ $$aSherbenou, Daniel W.
000000827 8564_ $$9540fed1d-d979-4629-b37b-e3423cf5be24$$s3457723$$uhttps://digitalcollections.ohsu.edu/record/827/files/830_etd.pdf
000000827 905__ $$a/rest/prod/xg/94/hp/58/xg94hp58h
000000827 909CO $$ooai:digitalcollections.ohsu.edu:827$$pstudent-work
000000827 980__ $$aTheses and Dissertations